Brief: Eris Lifesciences To Acquire Branded Formulations Businesses Of Biocon Biologics Pertaining To Indian Territory
March 14 (Reuters) - Eris Lifesciences Ltd ERIS.NS :
* AGREEED TO ACQUIRE BRANDED FORMULATIONS BUSINESSES OF BIOCON BIOLOGICS
PERTAINING TO INDIAN TERRITORY
* AGREED TO ACQUIRE 19% EQUITY STAKE IN SWISS PARENTERALS FROM PROMOTERS OF
COMPANY
Further company coverage: ERIS.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eris Lifesciences
See all newsIndia's Eris Lifesciences gains on strong quarterly results
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 1.84 Billion Rupees
Brief: Eris Lifesciences Says Krishnakumar Vaidyanathan Resigns As Executive Director & COO
Brief: Eris Lifesciences Ltd Says June-Quarter Consol Net Profit 1.42 Billion Rupees
Brief: Eris Lifesciences March-Quarter Consol Net Profit 2.82 Billion Rupees